Fire Fight: Smother the Flame of Type 2 Inflammation- Advances in Understanding and Managing Type 2 Inflammatory Diseases: A Clinical Forum

Program Overview

In this interactive panel discussion, 3 multidisciplinary clinical opinion leaders discuss type 2 Inflammation as an underlying cause of asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyps, with implications for therapeutic choices in patient care.

Credit Expired
CE Credit Expired
Expires: November 22, 2021

Target Audience

The educational design of this activity addresses the needs of physicians who specialize in allergy/immunology, dermatology, otolaryngology, pulmonology, and primary care.

Educational Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Describe the role of the type 2 inflammatory cascade in the underlying pathophysiology of atopic diseases
  • Identify patients with type 2 inflammatory diseases who are eligible for step-up therapies, including new and emerging biologics

Activity Faculty


Peter A. Lio, MD, FAAD

Clinical Assistant Professor, Dermatology & Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL


Joseph K. Han, MD

Professor, EVMS
Chief, Division of Rhinology and Endoscopic Sinus-Skull Base Surgery
Chief, Division of Allergy
President Elect, ARS
Chair Elect, AAAAI, RROAC
Eastern Virginia Medical School
Norfolk, VA


Anju T. Peters, MD, MS

Professor, Medicine
Division of Allergy-Immunology
Director, Clinical Research
Northwestern University Feinberg School of Medicine
Chicago, IL


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources